A novel acute-phase marker: Lipopolysaccharide binding protein (LBP)

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 3, 1999, Pages 271-274

  Schumann, Ralf R ^a,b   Zweigner, Janine ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Inst F Mikrobiol und Hyg Berlin   (Germany)

Author keywords

Acute phase; Lipopolysaccharide (LPS); LPS binding protein (LBP); Sepsis

Indexed keywords

ACUTE PHASE PROTEIN; ENDOTOXIN; LIPOPOLYSACCHARIDE;

CONFERENCE PAPER; EARLY DIAGNOSIS; HOST RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032922064     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.047     Document Type: Conference Paper

References (41)

1. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389:39-48.
2. Kushner I, and Maciewicz A. The acute phase response: an overview. In: Maciewicz A, Kushner I, Baumann H, editors. Acute phase proteins. Boca Raton: CRC Press, 1993:4-19.
3. Koj A. Acute Phase Reactants. In: Allison AC, editor. Structure and function of plasma proteins. New York: Plenum Press, 1974:73-94.
4. Fey GH, Gauldie J. The acute phase response of the liver in inflammation. In: Popper H, Schaffner F, editors. Progress in liver disease. Philadelphia: W.B. Saunders, Co., 1990:89-116.
5. Kushner I, Maciewicz A. Acute phase proteins as disease markers. Dis Markers 1987; 5:1-11.
6. Werner M, Cohnen G. Changes in serum proteins in the immediate postoperative period. Clin Sci 1969; 36:173-84.
7. McCabe WR. Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med 1973; 288:21-3.
8. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53:195-229.
9. Volanakis JE. Complement activation by C-reactive protein complexes. Ann NY Acad Sci 1982; 389:235-50.
10. Ezekowitz RAB, Day LE, Herman G. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 1988; 167:1034-46.
11. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249:1429-31.
12. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52:655-99.
13. Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280:1-8.
14. Baumann H, Gauldie J. The Acute Phase Response. Immunol Today 1994; 15:74-80.
15. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15:81-8.
16. Schumann RR, Kirschning C, Unbehaun A, Aberle H, Knopf H-P, Ulevitch RJ, et al. Lipopolysaccharide binding protein (LBP) is a secretory class 1 acute phase protein requiring binding of the transcription factor STAT-3, C/EBPβ, and AP-1. Mol Cell Biol 1996; 16:3490-503.
17. DaSilva P, Elkon JA, Hughes KB, Dyck GRV, Pepys MB. C-reactive protein levels in systemic lupus erythematosus: a classification criterion. Arthritis Rheum 1980; 23:770-82.
18. Maury CPJ. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci 1985; 68:233-8.
19. Brunkhorst F, Heinz U, Forycki Z. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 8:888-9.
20. Tobias P, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164:777-93.
21. Yang R, Mark M, Gray A, Huang A, Xie M, Zhang M, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395:284-8.
22. Gerard C. Bacterial infection. For whom the bell tolls. Nature 1998; 395:217-9.
23. Du X, Thompson P, Chan E, Ledesma J, Roe B, Clifton S, et al. Genetic and physical mapping of the Lps locus: identification of the Toll-4 receptor as a Candidate gene in the critical region. Blood Cells Mol Dis 1998; 24:340-55.
24. Pugin J, Schurer MC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90:2744-8.
25. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176:1665-71.
26. Schumann RR, Pfeil D, Lamping N, Kirschning C, Scherzinger G, Karawajew L, et al. LPS induces the rapid, CD14-dependent tyrosine phosphorylation of the mitogen activated protein kinase (MAPK) in human umbilical vein endothelial cells. Blood 1995; 87:2805-14.
27. Weinstein SL, Gold MR, DeFranco AL. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991; 88:4148-52.
28. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265:808-11.
29. Park CT, Wright SD. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J Biol Chem 1996; 271:18054-60.
30. Hailman E, Albers JJ, Wolfbauer G, Tu AY, Wright SD. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem 1996; 271:12172-8.
31. Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990; 29:1372-6.
32. Au-Young J, Fielding CJ. Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells: the carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer. Proc Natl Acad Sci USA 1992; 89:4094-8.
33. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AFT, Grant FJ, et al. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 1994; 269:9388-91.
34. Hubacek JA, Buchler C, Aslanidis C, Schmitz G. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Commun 1997; 236:427-30.
35. Kirschning CJ, Au-Young J, Lamping N, Reuter D, Pfeil D, Seilhamer J, et al. Similar organization of the lipopolysaccharide binding protein and phospholipid transfer protein (PLTP) genes suggest a common gene family of lipid binding proteins. Genomics 1997; 46:416-25.
36. Lamping N, Dettmer R, Schroder N, Pfeil D, Hallatschek W, Burger R, et al. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998; 101:2065-71.
37. Wurfel M, Monks B, Ingalls R, Dedrick R, Delude R, Zhou D, et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 1997; 186:2051-6.
38. Jack R, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997; 389:742-5.
39. Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995; 63:1020-6.
40. Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR, et al. Lipopolysaccharide activates Caspase-1 (interleukin-1-converting enzyme, ICE) in cultured monocytic and endothelial cells. Blood 1998; 91:577-84.
41. Kirschning CJ, Hallatschek W, Lamping N, Reuter D, Pfeil D, Schumann RR. Transcriptional activation of the acute phase protein lipopolysaccharide binding protein (LBP) involves transcription factors STAT-3, C/EBP, and AP-1. In: Faist E, editor. The immune consequences of trauma, shock and sepsis, mechanisms and therapeutic approaches. Bologna: Monduzzi Editore, 1997:807-10.